Medicare billing address
CMS Medicare provider billing file
114 E 800 NSpanish Fork, UT 84660
CMS public data · NPI 1821299751
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Chad Peterson, D.O.
Specialty
Credential
D.O.
NPI
1821299751
Primary source state
UT
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Chad Peterson, D.O. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
114 E 800 NCMS Doctors & Clinicians file
114 E 800In the 2024 CMS provider billing file, this NPI had 509 Medicare beneficiaries and 4,083 total services. The average beneficiary age was 76, and the average HCC risk score was 1.1.
Total Medicare allowed amount
$456,709.98
Total Medicare payment amount
$350,161.88
Medicare beneficiaries
509
Total services
4,083
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
68%
CMS beneficiary-panel share
Hyperlipidemia
61%
CMS beneficiary-panel share
Diabetes
32%
CMS beneficiary-panel share
Chronic kidney disease
25%
CMS beneficiary-panel share
Mood disorders
23%
CMS beneficiary-panel share
Ischemic heart disease
21%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 877 | $6.43 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 512 | $89.50 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 340 | $259.29 |
| Ultrasonic guidance for placement of radiation therapy fields | 339 | $173.54 |
| Superficial and/or low voltage radiation treatment delivery | 328 | $39.87 |
| Destruction of precancer skin growth, 1 growth | 280 | $52.70 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 194 | $0.98 |
| Biopsy of related skin growth, first growth | 164 | $89.98 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 146 | $606.20 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 146 | $6.80 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1821299751. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Cephalexin | Cephalexin | 201 | 201 | $970.65 |
| 2 | Betamethasone Dipropionate | Betamethasone Dipropionate | 63 | 63.5 | $2,412.16 |
| 3 | Triamcinolone Acetonide | Triamcinolone Acetonide | 59 | 67.5 | $760.41 |
| 4 | Minocycline Hcl | Minocycline Hcl | 36 | 40 | $962.04 |
| 5 | Fluorouracil | Fluorouracil | 26 | 26.3 | $1,710.84 |
| 6 | Mupirocin | Mupirocin | 25 | 25 | $212.24 |
| 7 | Clobetasol Propionate | Clobetasol Propionate | 24 | 28 | $1,211.35 |
| 8 | Terbinafine Hcl | Terbinafine Hcl | 20 | 24 | $216.81 |
| 9 | Methotrexate | Methotrexate Sodium | 16 | 27.9 | $454.51 |
| 10 | Doxycycline Hyclate | Doxycycline Hyclate | 15 | 20 | $704.35 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Western University Of Health Sciences College Of Dental Med
Graduation year
2003
Group/practice field
Aspen Dermatology Pllc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.